Need professional-grade analysis? Visit stockanalysis.com
$11.81B
519.27
375
N/A
Shanghai Yizhong Pharmaceutical Co Ltd (688091) trades on SHG in CNY. The company is classified in the Healthcare sector under the Drug Manufacturers - Specialty & Generic industry. The stock currently trades at CNY53.10, down 6.76% from the previous close.
Over the past year, 688091 has traded between a low of CNY41.20 and a high of CNY81.75. The stock has gained 11.3% over this period. It is currently 35.0% below its 52-week high.
Shanghai Yizhong Pharmaceutical Co Ltd has a market capitalization of $11.81B, with a price-to-earnings ratio of 519.27.
Shanghai Yizhong Pharmaceutical Co., Ltd. engages in the development of anti-tumor drugs and related products in China. It also offers paclitaxel polymer nanomicelles for the treatment of non-small cell lung cancer, as well as various types of cancer, including esophageal cancer, gastric cancer, nasopharyngeal carcinoma, pancreatic cancer, breast cancer, gynecological tumors, etc. The company was founded in 2009 and is headquartered in Shanghai, China.
Side-by-side comparison against top Healthcare peers.